Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease

Citations Over TimeTop 10% of 2015 papers

Abstract

The age-dependent deposition of amyloid-β peptides, derived from amyloid precursor protein (APP), is a neuropathological hallmark of Alzheimer's disease (AD). Despite age being the greatest risk factor for AD, the molecular mechanisms linking ageing to APP processing are unknown. Here we show that asparagine endopeptidase (AEP), a pH-controlled cysteine proteinase, is activated during ageing and mediates APP proteolytic processing. AEP cleaves APP at N373 and N585 residues, selectively influencing the amyloidogenic fragmentation of APP. AEP is activated in normal mice in an age-dependent manner, and is strongly activated in 5XFAD transgenic mouse model and human AD brains. Deletion of AEP from 5XFAD or APP/PS1 mice decreases senile plaque formation, ameliorates synapse loss, elevates long-term potentiation and protects memory. Blockade of APP cleavage by AEP in mice alleviates pathological and behavioural deficits. Thus, AEP acts as a δ-secretase, contributing to the age-dependent pathogenic mechanisms in AD.

Related Papers

• → The role of APP and BACE1 trafficking in APP processing and amyloid-β generation(2013)197 cited
• → Inhibition of amyloid precursor protein processing by β-secretase through site-directed antibodies(2005)76 cited
• → Inhibition of amyloid β‐peptide production by blockage of β‐secretase cleavage site of amyloid precursor protein(2007)14 cited
• → Trafficking and Proteolytic Processing of APP(2012)1,060 cited
• → The orphan drug dichloroacetate reduces amyloid beta-peptide production whilst promoting non-amyloidogenic proteolysis of the amyloid precursor protein(2021)